Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00102492 · ClinicalTrials.gov registry record · Phase 2
Study Of GW679769 In Major Depressive Disorder
A Phase 2 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 356
- Enrollment target
NCT00102492 is a Phase 2 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 356 participants.
The verdict
NCT00102492, a Phase 2 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 356 participants
- Enrollment target
Study Summary
This is a placebo-controlled, fixed dose study that will evaluate the efficacy and safety of GW679769 in subjects with major depressive disorder.
Interventions
- DRUG GW679769
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 356 participants |
| Start Date | 2004-10 |
| Est. Completion | 2006-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00102492
The ClinicalTrials.gov registry entry for NCT00102492 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 356 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GW679769 is the first listed.
NCT00102492 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00102492 about?
NCT00102492 is a clinical study titled "Study Of GW679769 In Major Depressive Disorder". This is a placebo-controlled, fixed dose study that will evaluate the efficacy and safety of GW679769 in subjects with major depressive disorder.
What is the current status of trial NCT00102492?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 356 participants. The study started on 2004-10. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00102492?
The interventions under investigation include: GW679769 (DRUG).
Who is sponsoring clinical trial NCT00102492?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.